
Saul N. Faust
Southampton, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 236 publications
The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.
Journal: Vaccine
Published: March 26, 2026
Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Published: March 23, 2026
Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
Journal: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
Published: March 23, 2026
Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
Journal: Intensive care medicine
Published: March 23, 2026
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.
Journal: Vaccine
Published: March 19, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trial.
Journal: The Lancet. Infectious diseases
Published: January 16, 2026
BPZE1 vaccination induces IL-17+ and IL-22+ CD4+ T cells associated with nasal mucosal secretory IgA responses in humans: effects on virulent Bordetella pertussis colonisation.
Journal: NPJ vaccines
Published: December 29, 2025
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.
Journal: The New England journal of medicine
Published: October 29, 2025
Enablers and barriers to participation in vaccine trials: a narrative synthesis.
Journal: Vaccine
Published: September 25, 2025
Quality of life of X-linked agammaglobulinemia patients in the United Kingdom.
Journal: Journal of human immunity
Published: September 15, 2025
A phase I, needle free, dose escalation clinical trial of pEVAC-PS, a candidate pan-Sarbecovirus Vaccine.
Journal: The Journal of infection
Published: September 09, 2025
Last Updated: 09/26/2026